Opportunity Information: Apply for PAR 18 335
The Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 - Clinical Trial Not Allowed) is a National Institutes of Health (NIH) discretionary grant opportunity (Funding Opportunity Number PAR-18-335) designed specifically to strengthen research administration capacity at institutions based in low- and middle-income countries (LMICs). Rather than funding scientific experiments or clinical studies, the focus is on building the institutional ability to properly manage NIH-funded projects, with an emphasis on infectious disease research activities supported by the National Institute of Allergy and Infectious Diseases (NIAID). In practical terms, this program targets the people and systems that sit behind research: the senior administrators and institutional offices responsible for grant submission, award management, compliance, reporting, and stewardship of federal funds.
The central purpose of the award is to provide advanced training in NIH grants management for senior administrative staff at eligible LMIC research institutions. The intent is to help these administrators develop deeper, working-level competence in the full lifecycle of an NIH award, including understanding NIH policies and meeting U.S. federal requirements that apply to foreign institutions receiving NIH support. By investing in the professional development of experienced institutional leaders (as opposed to entry-level staff), the program aims to produce immediate, institution-wide improvements in how grants are overseen and how research operations remain compliant, auditable, and well-documented.
A key goal of the FOA is improved oversight of NIAID grant awards at foreign institutions in LMICs. That includes strengthening internal controls and administrative practices that reduce common risks in sponsored projects, such as weak documentation, delayed reporting, inconsistent adherence to award terms and conditions, and gaps in financial management processes. The broader public benefit is that stronger research administration helps protect research integrity, ensures funds are used as intended, and supports sustainable partnerships between NIH and LMIC institutions by making award implementation smoother and more reliable over time.
Eligibility is oriented toward non-U.S. entities, explicitly including non-domestic (non-U.S.) organizations. This makes the opportunity particularly relevant to universities, research institutes, and other eligible organizations located outside the United States that manage or seek to manage NIH-funded work, especially in areas connected to global infectious diseases. The program sits within NIH's health-related funding activity (CFDA 93.855) and uses the grant funding instrument. The "Clinical Trial Not Allowed" designation means proposed activities must not include clinical trials; the emphasis is administrative development and training rather than interventional human subjects research.
From an administrative standpoint, the FOA was created on 2017-10-31, with an original closing date listed as 2020-07-31. The source data does not specify an award ceiling or the expected number of awards, so applicants would typically need to consult the full announcement text and any related NIH guidance for budget limits, project period parameters, and detailed application instructions. Overall, the opportunity is best understood as a capacity-building grant: it supports the strengthening of grants management leadership and compliance infrastructure at LMIC institutions so they can more effectively administer NIH awards, meet required standards, and sustain high-quality research operations aligned with NIH and NIAID expectations.Apply for PAR 18 335
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11-Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.855.
- This funding opportunity was created on 2017-10-31.
- Applicants must submit their applications by 2020-07-31. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp - Clinical Trial Not Allowed)
Previous opportunity: USAID/Indonesia Harmoni: Towards Inclusion and Resilience Activity
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 18 335
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 18 335) also looked into and applied for these:
| Funding Opportunity |
|---|
| Phenotypic and Functional Studies on FOXO3 Human Longevity Variants to Inform Potential Therapeutic Target Identification Research (R01 Clinical Trial Optional) Apply for PAR 18 026 Funding Number: PAR 18 026 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional) Apply for PAR 18 296 Funding Number: PAR 18 296 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIA Program Project Applications (P01 Clinical Trial Optional) Apply for PAR 18 297 Funding Number: PAR 18 297 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| 93.067 Apply for CDC RFA GH13 1368A Funding Number: CDC RFA GH13 1368A Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Program for Extramural/Intramural Alcohol Research Collaborations (U01 Clinical Trial Optional) Apply for PAR 18 195 Funding Number: PAR 18 195 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Increasing the Use of Medications for the Treatment of Alcohol Use Disorders (R01 Clinical Trial Optional) Apply for PAR 18 196 Funding Number: PAR 18 196 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clarifying the Relationship between Delirium and Alzheimers Disease and Related Dementias (R21/R33 Clinical Trial Optional) Apply for PAR 18 181 Funding Number: PAR 18 181 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alcohol Impairment of Immune Function, Host Defense and Tissue Homeostasis (R01 Clinical Trial Optional) Apply for PA 18 191 Funding Number: PA 18 191 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Revision Applications for Validation of Mobile/Wireless Health Tools for Measurement and Intervention (R01) (Clinical Trials Not Allowed) Apply for PA 18 338 Funding Number: PA 18 338 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Phased Innovation Award for Mechanistic Studies to Optimize Mind and Body Interventions in NCCIH High Priority Research Topics (R61/R33 Clinical Trial Required) Apply for PAR 18 114 Funding Number: PAR 18 114 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Improving Outcomes for Disorders of Human Communication (R01 Clinical Trial Optional) Apply for PA 18 287 Funding Number: PA 18 287 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Minority HIV/AIDS Research Initiative (MARI) to Build HIV Prevention, Treatment and Research Capacity in Disproportionately Affected Black and Hispanic Communities and Among Historically Underrepresented Researchers Apply for RFA PS 16 00103CONT18 Funding Number: RFA PS 16 00103CONT18 Agency: Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: Case Dependent |
| Innovation Award for Mechanistic Studies to Optimize Mind and Body Interventions in NCCIH High Priority Research Topics (R33 Clinical Trial Required) Apply for PAR 18 115 Funding Number: PAR 18 115 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Emerging Infectious Sentinel Networks (EISN) Research Apply for RFA CK 16 00103CONT18 Funding Number: RFA CK 16 00103CONT18 Agency: Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: Case Dependent |
| NCCIH Mind and Body Clinical Trial Cooperative Agreement (U01 Clinical Trial Required) Apply for PAR 18 118 Funding Number: PAR 18 118 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Improving Outcomes for Disorders of Human Communication (R21 Clinical Trial Optional) Apply for PA 18 288 Funding Number: PA 18 288 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Population-based HIV Impact Assessments in Resource-Constrained Settings under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH14 1409A Funding Number: CDC RFA GH14 1409A Agency: Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Human Studies to Evaluate Promising Medications to Treat Alcohol Use Disorder (R03 Clinical Trial Required) Apply for PA 18 198 Funding Number: PA 18 198 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Human Studies to Evaluate Promising Medications to Treat Alcohol Use Disorder (R21 Clinical Trial Required) Apply for PA 18 197 Funding Number: PA 18 197 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Systems Biology Approaches using Non-Mammalian Laboratory Animals to Uncover Causes of Neurodegeneration that Might Underlie Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed) Apply for RFA AG 18 021 Funding Number: RFA AG 18 021 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 18 335", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.